These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18090153)

  • 1. Optimizing methods for the diagnosis of pancreatic cancer.
    Brugge WR
    J Clin Gastroenterol; 2007; 41(10):869-70. PubMed ID: 18090153
    [No Abstract]   [Full Text] [Related]  

  • 2. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
    Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
    J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis.
    Bournet B; Souque A; Senesse P; Assenat E; Barthet M; Lesavre N; Aubert A; O'Toole D; Hammel P; Levy P; Ruszniewski P; Bouisson M; Escourrou J; Cordelier P; Buscail L
    Endoscopy; 2009 Jun; 41(6):552-7. PubMed ID: 19533561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kras oncogene and pancreatic cancer: thirty years after].
    Bournet B; Dufresne M; Selves J; Torrisani J; Cordelier P; Buscail L
    Med Sci (Paris); 2013 Nov; 29(11):991-7. PubMed ID: 24280502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic adenocarcinoma.
    Ryan DP; Hong TS; Bardeesy N
    N Engl J Med; 2014 Sep; 371(11):1039-49. PubMed ID: 25207767
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraductal tubular carcinoma of the pancreas: case report with molecular analysis.
    Furukawa T; Hatori T; Fukuda A; Fujita I; Yamamoto M
    Pancreas; 2009 Mar; 38(2):235-7. PubMed ID: 19238030
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: a histochemical, immunohistochemical, and molecular report.
    Bellevicine C; Malapelle U; Iaccarino A; Schettino P; Napolitano V; Zeppa P; Troncone G
    Diagn Cytopathol; 2013 Jan; 41(1):77-80. PubMed ID: 23008087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic markers in the evaluation of pancreatic masses.
    Ginestà MM; Mora J; Mayor R; Farré A; Peinado MA; Busquets J; Serrano T; Capellá G; Fabregat J
    J Clin Pathol; 2013 Mar; 66(3):192-7. PubMed ID: 23135349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The added value of using mutational profiling in addition to cytology in diagnosing aggressive pancreaticobiliary disease: review of clinical cases at a single center.
    Malhotra N; Jackson SA; Freed LL; Styn MA; Sidawy MK; Haddad NG; Finkelstein SD
    BMC Gastroenterol; 2014 Aug; 14():135. PubMed ID: 25084836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUS-guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: a pilot study.
    Siddiqui AA; Kowalski TE; Kedika R; Roy A; Loren DE; Ellsworth E; Adler D; Finkelstein SD
    Gastrointest Endosc; 2013 Apr; 77(4):669-70. PubMed ID: 23498145
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of predictive markers in oncology: are phase 3 trials always required?
    Markman M
    Oncology; 2011; 81(1):1-2. PubMed ID: 21894048
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological identification of ampullary adenocarcinomas.
    Relias V; Saif MW
    JOP; 2014 Jul; 15(4):306-7. PubMed ID: 25076327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of mutational profiling of the cytocentrifugation supernatant fluid from fine-needle aspiration of pancreatic solid mass lesions.
    Deftereos G; Finkelstein SD; Jackson SA; Ellsworth EM; Krishnamurti U; Liu Y; Silverman JF; Binkert CR; Ujevich BA; Mohanty A
    Mod Pathol; 2014 Apr; 27(4):594-601. PubMed ID: 24051700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
    Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
    Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
    Shi C; Fukushima N; Abe T; Bian Y; Hua L; Wendelburg BJ; Yeo CJ; Hruban RH; Goggins MG; Eshleman JR
    Cancer Biol Ther; 2008 Mar; 7(3):353-360. PubMed ID: 18075308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shining the spotlight on shed KRAS in pancreatic cancer.
    Sempere LF; Korc M
    Cancer Biol Ther; 2008 Mar; 7(3):361-3. PubMed ID: 18614859
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor.
    Tada M; Komatsu Y; Kawabe T; Sasahira N; Isayama H; Toda N; Shiratori Y; Omata M
    Am J Gastroenterol; 2002 Sep; 97(9):2263-70. PubMed ID: 12358243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy, p53, and pancreatic cancer.
    Iacobuzio-Donahue CA; Herman JM
    N Engl J Med; 2014 Apr; 370(14):1352-3. PubMed ID: 24693896
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous fine needle aspiration biopsy of the pancreas. Cytodiagnosis of pancreatic carcinoma.
    Tao LC; Ho CS; McLoughlin MJ; McHattie J
    Acta Cytol; 1978; 22(4):215-20. PubMed ID: 281823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.